National Health Act 1953 Amendment determination under section 84AF Responsible Persons (No. PB 80 of 2007) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 80 of 2007
Amendment determination under section 84AF of the National Health Act 1953
I, STEPHEN DELLAR, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, make this instrument under section 84AF of the National Health Act 1953.
Dated 2 October 2007
STEPHEN DELLAR
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Determination – Responsible Persons
1 Commencement
This instrument commences on 1 November 2007.
2 Amendment of PB 50 of 2007
Schedule 1 amends PB 50 of 2007.
Schedule 1 Amendments
[1] Schedule 1, after items dealing with Bleomycin
insert in the columns in the order indicated:
| Bortezomib | Powder for injection 3.5 mg (with any determined brand of sodium chloride injection as the required solvent) | Injection | Velcade | Janssen-Cilag Pty Ltd | 47 000 129 975 |
[2] Schedule 1, after item dealing with Ceftriaxone in the form Powder for injection 1 g (as sodium) (DBL Ceftriaxone)
insert in the columns in the order indicated:
| Ceftriaxone | Powder for injection 1 g (as sodium) | Injection | Max Pharma Pty Ltd | Max Pharma Pty Ltd | 93 121 857 878 |
[3] Schedule 1, after items dealing with Celecoxib
insert in the columns in the order indicated:
| Cephalexin | Capsule 250 mg (anhydrous) | Oral | Cephalexin-Lupin | Max Pharma Pty Ltd | 93 121 857 878 |
[4] Schedule 1, after item dealing with Cephalexin in the form Capsule 250 mg (anhydrous) (Terry White Chemists Cephalexin)
insert in the columns in the order indicated:
| Cephalexin | Capsule 500 mg (anhydrous) | Oral | Cephalexin-Lupin | Max Pharma Pty Ltd | 93 121 857 878 |
[5] Schedule 1, after item dealing with Glucose Indicator — Blood in the form Electrode strips, 50 (Omnitest Plus)
insert in the columns in the order indicated:
| Glucose Indicator — Blood | Electrode strips, 50 (Optium Omega) | For external use | (Optium Omega) | Abbott Australasia Pty Ltd | 95 000 180 389 |
[6] Schedule 1, after items dealing with Ifosfamide
insert in the columns in the order indicated:
| Imatinib | Tablet 100 mg (as mesylate) | Oral | Glivec | Novartis Pharmaceuticals Australia Pty Ltd | 18 004 244 160 |
| Imatinib | Tablet 400 mg (as mesylate) | Oral | Glivec | Novartis Pharmaceuticals Australia Pty Ltd | 18 004 244 160 |
[7] Schedule 1, item dealing with Loperamide in the form Capsule containing loperamide hydrochloride 2 mg (Imodium)
omit in the columns in the order indicated:
| Janssen-Cilag Pty Ltd | 47 000 129 975 |
and substitute:
| Johnson & Johnson Pacific Pty Ltd | 73 001 121 446 |
[8] Schedule 1, after item dealing with Meloxicam in the form Tablet
15 mg (GenRx Meloxicam)
insert in the columns in the order indicated:
| Meloxicam | Tablet 15 mg | Oral | Meloxibell | Bellwether Pharma Limited | 15 109 403 287 |
| Meloxicam | Tablet 15 mg | Oral | Meloxicam Ranbaxy | Ranbaxy Australia Pty Limited | 17 110 871 826 |
[9] Schedule 1, after item dealing with Meloxicam in the form Tablet
15 mg (Moxicam 15)
insert in the columns in the order indicated:
| Meloxicam | Tablet 15 mg | Oral | Pharmacor Meloxicam 15 | Pharmacor Limited | 58 121 020 835 |
[10] Schedule 1, after item dealing with Meloxicam in the form Tablet
7.5 mg (GenRx Meloxicam)
insert in the columns in the order indicated:
| Meloxicam | Tablet 7.5 mg | Oral | Meloxibell | Bellwether Pharma Limited | 15 109 403 287 |
| Meloxicam | Tablet 7.5 mg | Oral | Meloxicam Ranbaxy | Ranbaxy Australia Pty Limited | 17 110 871 826 |
[11] Schedule 1, after item dealing with Meloxicam in the form Tablet
7.5 mg (Moxicam 7.5)
insert in the columns in the order indicated:
| Meloxicam | Tablet 7.5 mg | Oral | Pharmacor Meloxicam 7.5 | Pharmacor Limited | 58 121 020 835 |
[12] Schedule 1, after item dealing with Mirtazapine in the form Tablet
30 mg (Axit 30)
insert in the columns in the order indicated:
| Mirtazapine | Tablet 30 mg | Oral | Chem mart Mirtazapine | GenRx Pty Ltd | 52 096 916 148 |
| Mirtazapine | Tablet 30 mg | Oral | GenRx Mirtazapine | GenRx Pty Ltd | 52 096 916 148 |
[13] Schedule 1, after item dealing with Mirtazapine in the form Tablet
30 mg (Remeron)
insert in the columns in the order indicated:
| Mirtazapine | Tablet 30 mg | Oral | Terry White Chemists Mirtazapine | GenRx Pty Ltd | 52 096 916 148 |
[14] Schedule 1, after item dealing with Perindopril with Indapamide in the form Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg (GenRx Perindopril/Indapamide 4/1.25)
insert in the columns in the order indicated:
| Perindopril with Indapamide | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | Perindo Combi 4/1.25 | Alphapharm Pty Ltd | 93 002 359 739 |
[15] Schedule 1, after item dealing with Pravastatin in the form Tablet containing pravastatin sodium 20 mg (Terry White Chemists Pravastatin)
insert in the columns in the order indicated:
| Pravastatin | Tablet containing pravastatin sodium 20 mg | Oral | Vastoran | Ranbaxy Australia Pty Ltd | 17 110 871 826 |
[16] Schedule 1, after item dealing with Pravastatin in the form Tablet containing pravastatin sodium 40 mg (Terry White Chemists Pravastatin)
insert in the columns in the order indicated:
| Pravastatin | Tablet containing pravastatin sodium 40 mg | Oral | Vastoran | Ranbaxy Australia Pty Ltd | 17 110 871 826 |
[17] Schedule 1, item dealing with Simvastatin in the form Tablet 5 mg
omit in the columns in the order indicated:
| Simvastatin | Tablet 5 mg | Oral | Simvastatin Winthrop | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |
[18] Schedule 1, item dealing with Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate in the form Enemas 3.125 g-450 mg-45 mg in 5 ml, 12
omit in the columns in the order indicated:
| Pfizer Pty Ltd | 50 008 422 348 |
and substitute:
| Johnson & Johnson Pacific Pty Ltd | 73 001 121 446 |
[19] Schedule 1, after items dealing with Tacrolimus
insert in the columns in the order indicated:
| Tamarindus indica seed polysaccharide | Eye drops 10 mg per mL, 0.5 mL, 20 | Application to the eye | Visine Professional | Johnson & Johnson Pacific Pty Ltd | 73 001 121 446 |
[20] Schedule 1, after item dealing with Vancomycin in the form Capsule 250 mg (250,000 I.U.) (as hydrochloride)
insert in the columns in the order indicated:
| Vancomycin | Powder for injection 1 g (1,000,000 I.U.) as hydrochloride | Injection | Hospira Australia Pty Ltd | Hospira Australia Pty Ltd | 58 097 064 330 |
Schedule 1, item dealing with Vancomycin in the form Powder for injection 500 mg (500,000 i.u.) as hydrochloride (Vancocin)
omit from the column headed “Brand”:
Vancocin
and substitute:
Vancocin CP
0
0
0